The disease burden may be significant both in case of overt clinical outbreaks and due to the impairment of immune status, which may lead to poor productive performance, vaccine failures, secondary infections, etc.
← all excerpts
First Detection and Molecular Characterization of Novel Variant Infectious Bursal Disease Virus (Genotype A2dB1b) in Egypt.
1
—
—